Date:  May 11, 2005

Time:  5:30pm to 9:15pm

Location:  Deaconess Health & Education Center

3.0 Hours of Category I CME credit

Contact Gerry Bozarth, CME coordinator, at 325-5010 with any questions.

Course Description:
This CME activity is designed for the primary care clinician where they will be given an overview of New Drug Therapies for rebound headaches, arthritis, and antibiotic use for MRSA and Superbugs. First, this activity will focus on new treatment strategies for rebound headaches. Next, biotech antirheumatics will be explored in the treatment of arthritis and finally, antibiotic use to combat MRSA and Superbugs will be covered.

Faculty:

William Bender, M.D.
Bender & Wurst Neurology/Spokane Headache Clinic

Gary Craig, M.D.  
Rockwood Clinic 

Colleen Terriff, R.PH., PharmD.
Deaconess Medical Center

Agenda:

5:30 – 5:55 pm          Registration

5:55 –6:00 pm           Program Welcome & Announcements 

6:00 – 7:00 pm          “Rebound Headaches: New Thoughts about Treatment Patterns for Headaches”

                                    William Bender, M.D.   

7:00 – 8:00 pm         “The Good, The Bad, and The Ugly: New Antirheumatics”

                                    Gary Craig, M.D.

8:00 – 8:15pm            Break

8:15 – 9:15pm            “New Antibiotic Treatment Modalities for MRSA and Superbugs”

                                      Colleen Terriff, R.PH., PharmD.        

Course Objectives: At the conclusion of this course program the participant will be able to:

Describe the basic science & clinical use of biotech antirheumatics.

Discuss new pharmacologic treatment patterns for rebound headache.

Explore new antibiotic treatment modalities for MRSA and Superbugs